Recombinant Human EDNRA VLP, Active
Beta LifeScience
SKU/CAT #: BLK-03247P
Immobilized Human EDNRA VLP at 5ug/ml (100ul/well) on the plate. Dose response curve for Anti-EDNRA Antibody, hFc Tag with the EC50 of 57.0ng/ml determined by ELISA (QC Test).
Recombinant Human EDNRA VLP, Active
Beta LifeScience
SKU/CAT #: BLK-03247P
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
| Description | Recombinant Human EDNRA VLP is expressed from HEK293.It contains Met1-Asn427 (It may have cross reaction with anti-His antibody). |
| Gene Background | The endothelin-A receptor (Ednra) is involved in several physiological, pathological, and developmental pathways. Known for its function in vasoconstriction after being activated by endothelin-1, Ednra also controls cephalic neural crest cell development and appears to play a role in several pathologies, including cancer and periodontitis. |
| Accession | P25101-1 |
| Target Symbol | EDNRA |
| Synonyms | EDNRA; ET-A; ETA-R; hET-AR; ETA; ETRA |
| Species | Human |
| Expression System | Mammalian Cell |
| Expression Range | Met1-Asn427 |
| Mol. Weight | The target protein has a predicted MW of 76.3 kDa. |
| Form | Liquid |
| Formulation | Supplied as 0.22 um filtered solution in PBS, 150mM L-Arginine (pH 7.4). Notice: If you need it for immunization, water-soluble adjuvant is recommended. |
| Endotoxin | Less than 1 EU per ug by the LAL method. |
| Activity | Immobilized Human EDNRA VLP at 5ug/ml (100ul/well) on the plate. Dose response curve for Anti-EDNRA Antibody, hFc Tag with the EC50 of 57.0ng/ml determined by ELISA (QC Test). |
| Biotinylated | No |
| Shipping | Shipped with dry ice. |
| Storage | Valid for 12 months from date of receipt when stored at -80°C.; Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
